Design Therapeutics, Inc. (DSGN) Ownership

$4.93

north_east
$0.23 (4.78%)
Day's range
$4.65
Day's range
$5.04

Design Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SR ONE CAPITAL MANAGEMENT, LP 02/13/2025 6.53 M $40.27 M   0.00% 11.53%
MACKENZIE FINANCIAL CORP 02/20/2025 4.95 M $561.83 M   130.42% 8.74%
LOGOS GLOBAL MANAGEMENT LP 02/14/2025 4.22 M $26.02 M   0.00% 7.45%
CONESTOGA CAPITAL ADVISORS, LLC 01/24/2025 3.15 M $357.90 M   -0.57% 5.56%
DURABLE CAPITAL PARTNERS LP 02/14/2025 2.92 M $331.21 M   -15.63% 5.15%
JARISLOWSKY, FRASER LTD 02/14/2025 2.71 M $306.21 M   -4.68% 4.78%
BLACKROCK FUNDING, INC. /DE 02/07/2025 2.58 M $15.92 M   9.36% 4.56%
FIERA CAPITAL CORP 01/29/2025 2.54 M $288.75 M   -1.39% 4.49%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 02/18/2025 1.95 M $12.05 M   3.22% 3.45%
PRIMECAP MANAGEMENT CO/CA/ 02/10/2025 1.92 M $217.83 M   -9.31% 3.39%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2025 1.90 M $215.85 M   -0.58% 3.36%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 1.86 M $11.46 M   15.99% 3.28%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 02/14/2025 1.77 M $200.72 M   6.08% 3.12%
BAKER BROS. ADVISORS LP 02/14/2025 1.74 M $10.76 M   0.00% 3.08%
FRANKLIN RESOURCES INC 02/12/2025 1.69 M $192.50 M   23.88% 2.99%
TANG CAPITAL MANAGEMENT LLC 02/14/2025 1.48 M $9.14 M   0.00% 2.62%
GENEVA CAPITAL MANAGEMENT LLC 02/06/2025 1.46 M $165.76 M   -1.19% 2.58%
ALMITAS CAPITAL LLC 02/14/2025 1.32 M $8.17 M   0.00% 2.34%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 02/12/2025 1.20 M $136.18 M   114.35% 2.12%
CONGRESS ASSET MANAGEMENT CO /MA 01/30/2025 1.18 M $134.12 M   -2.58% 2.09%
NORGES BANK 02/12/2025 1.12 M $126.92 M   100.00% 1.97%
TD ASSET MANAGEMENT INC 02/11/2025 899,762 $102.22 M   3.24% 1.59%
RIVERBRIDGE PARTNERS LLC 01/17/2025 800,923 $90.98 M   -7.54% 1.41%
DRIEHAUS CAPITAL MANAGEMENT LLC 02/14/2025 776,082 $4.79 M   100.00% 1.37%
BLACKROCK FUNDING, INC. /DE 02/07/2025 769,753 $87.44 M   9.08% 1.36%
NATIONAL BANK OF CANADA /FI/ 02/12/2025 730,778 $83.15 M   4.52% 1.29%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 01/29/2025 665,134 $75.50 M   18.16% 1.17%
LORD, ABBETT & CO. LLC 02/14/2025 657,712 $74.72 M   -2.26% 1.16%
JANUS HENDERSON GROUP PLC 02/14/2025 635,722 $72.23 M   0.56% 1.12%
GW&K INVESTMENT MANAGEMENT, LLC 02/05/2025 601,962 $68.38 M   -1.95% 1.06%
WESTFIELD CAPITAL MANAGEMENT CO LP 02/11/2025 595,448 $67.64 M   1.76% 1.05%
ACADIAN ASSET MANAGEMENT LLC 02/11/2025 567,604 $3.50 M   -2.67% 1.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 02/14/2025 565,671 $64.39 M   -3.28% 1.00%
BIOIMPACT CAPITAL LLC 02/14/2025 559,547 $3.45 M   100.00% 0.99%
D. E. SHAW & CO., INC. 02/14/2025 512,330 $3.16 M   -12.10% 0.90%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 02/12/2025 501,486 $56.97 M   6.56% 0.89%
PRAESIDIUM INVESTMENT MANAGEMENT COMPANY, LLC 02/14/2025 481,725 $54.72 M   100.00% 0.85%
BANK OF NOVA SCOTIA 02/13/2025 459,576 $52.23 M   1.19% 0.81%
SEGALL BRYANT & HAMILL, LLC 02/11/2025 447,808 $50.87 M   2.11% 0.79%
BAIRD FINANCIAL GROUP, INC. 02/14/2025 430,369 $48.89 M   -8.78% 0.76%
VONTOBEL HOLDING LTD. 01/30/2025 430,016 $48.82 M   104.50% 0.76%
ECOR1 CAPITAL, LLC 02/14/2025 426,683 $2.63 M   692.59% 0.75%
PREMIER FUND MANAGERS LTD 02/12/2025 411,419 $46.95 M   0.00% 0.73%
NEUBERGER BERMAN GROUP LLC 02/13/2025 396,740 $45.07 M   -0.58% 0.70%
CLEARBRIDGE INVESTMENTS, LLC 02/12/2025 352,421 $40.04 M   -16.89% 0.62%
MORGAN STANLEY 02/14/2025 346,183 $2.14 M   -19.27% 0.61%
BLAIR WILLIAM & CO/IL 02/12/2025 325,958 $37.03 M   3.68% 0.58%
DF DENT & CO INC 02/12/2025 270,557 $30.74 M   -3.26% 0.48%
MORGAN STANLEY 02/14/2025 269,596 $30.63 M   -24.52% 0.48%
ARTISAN PARTNERS LIMITED PARTNERSHIP 02/12/2025 257,935 $29.28 M   -28.77% 0.46%

Design Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 405 institutional investors and hedge funds held shares of Design Therapeutics, Inc.. The most heavily invested institutionals were:

SR ONE CAPITAL MANAGEMENT, LP: 6.53 M

MACKENZIE FINANCIAL CORP: 4.95 M

Logos Global Management LP: 4.22 M

BlackRock Funding, Inc. /DE: 3.35 M

Conestoga Capital Advisors, LLC: 3.15 M

Durable Capital Partners LP: 2.92 M

156.59% of Design Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 80.76 M shares in the last 24 months. This purchase volume represents approximately $398.12 M in transactions.